Todd Brady
InvestorFounderDirector of Finance & Investments at Brace Pharma · Board director at Avidity Biosciences · Board director at Tyrogenex
FoundedAvidity BiosciencesTyrogenex
About
Brady leads finance and investments at Brace Pharma Capital and serves as a director for portfolio companies including GeNO, Avidity Biosciences, and Tyrogenex. He has a background across equity research, asset management, private equity, and corporate banking, holds an MBA from Schulich School of Business, and is a CFA charterholder.
Board director at Avidity Biosciences
Intro paths
→
In turn, Todd can intro founders to Avidity Biosciences's investors below.
Avidity Biosciences's investors · 2
Co-founders at Avidity Biosciences
TW
Troy Wilson PhD., JDExecutive Officer, Director
PK
P. Kent HawrylukExecutive Officer
ME
Mark E. DavisDirector
FM
Frank McCormickDirector
TW
Troy WilsonExecutive Officer, Director
Board director at Tyrogenex
Intro paths
→
In turn, Todd can intro founders to Tyrogenex's investors below.
Tyrogenex's investors · 1
Co-founders at Tyrogenex
CL
Chris LiangExecutive Officer, Director
MW
Michael WebbExecutive Officer, Director
JS
Joseph StraightExecutive Officer
SG
Sheridan G. SnyderExecutive Officer, Director
DL
Dennis L. PalmgrenDirector
SD
Sheridan D. SnyderExecutive Officer
Colleagues at Brace Pharma
Frequently asked questions
- Where does Todd Brady work?
- Todd Brady is Director of Finance & Investments at Brace Pharma and Founder at Avidity Biosciences and Founder at Tyrogenex.
- What companies did Todd Brady found?
- Todd Brady founded Avidity Biosciences, Tyrogenex.